Sign inJoin waitlistJoin the waitlist

Margaret Fang

Chief, Division of Hospital Medicine · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

Division of Hospital Medicine · University of California (San Francisco) School of Medicine
Present
University of California (San Francisco) School of Medicine
Present

Internal Medicine
Massachusetts General Hospital
2001–2002
Internal Medicine
Beth Israel Deaconess Medical Center
1998–2001
Harvard School of Public Health
Feinberg School of Medicine
1994–1998
Northwestern University
1991–1994

Research

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American…
Stroke · 2014 · 3,006 citations
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice…
Chest · 2012 · 742 citations
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Journal of the American College of Cardiology · 2011 · First of 7 authors · Corresponding · 724 citations

Alan Go
45 papers
DS
Daniel Singer
30 papers
Anna Parks
17 papers · 12 as a fellow
Andrew Auerbach
14 papers
Kenneth Covinsky
10 papers
Aksharananda Rambachan
9 papers · 1 as a fellow
Kirsten Kangelaris
9 papers
Nader Najafi
7 papers
Elaine Hylek
6 papers
Anne Curtis
5 papers
Ashraf Abugroun
5 papers
Janice Schwartz
5 papers

Grants

Use and Outcomes of Anticoagulants for the Treatment and Prevention of Thrombosis Among Hospitalized Patients
National Heart, Lung, and Blood Institute · K24
Contact PI · $731K · University of California, San Francisco
2018–2024
Supplement to Direct-Acting Oral Anticoagulants: Anticoagulant Activity in Understudied Older NVAF Patients
National Institute on Aging · R21
PI · $540.6K · University of California, San Francisco
2020–2023
Anticoagulation Treatment and Long-Term Outcomes After Venous Thromboembolism
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.6M · University of California, San Francisco
2010–2016
Risks of Warfarin for Elders with Atrial Fibrillation
National Institute on Aging · K23
Contact PI · $865.8K · University of California, San Francisco
2006–2012

Clinical trials

COVID-19 and Venous Thromboembolism Risk
Principal investigator · Completed
University of California, San Francisco
2020–2022
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
Principal investigator · Completed
University of California, San Francisco
2010–2022